Appointment booking for Dr. Thomas Mccall, MD is currently not available.Dr. Thomas Mccall, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Thomas Mccall, MD (he/him) is a Pediatrician in Highlands Ranch, CO with over 17 years of experience. What is your opinion of Dr. Thomas Mccall, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Thomas Mccall, MD has received over $957 which includes payments from the following companies:
$168.45 from Pfizer Inc.
$101.90 from GlaxoSmithKline, LLC.
$72.03 from Ironshore Pharmaceuticals Inc.
$66.22 from Shire North American Group Inc
$59.56 from Kaleo, Inc.
$59.16 from Neos Therapeutics, LP
$57.41 from Tris Pharma Inc
$52.64 from Phadia US Inc.
$45.19 from Mylan Specialty L.P.
$38.49 from Meda Pharmaceuticals, Inc.
$33.87 from Aerocrine, Inc
$33.84 from Sobi, Inc
$33.10 from Cranial Technologies, Inc
$32.96 from AstraZeneca Pharmaceuticals LP
$25.95 from Merck Sharp & Dohme Corporation
$20.73 from Galderma Laboratories, L.P.
$17.27 from Teva Pharmaceuticals USA, Inc.
$14.66 from Noven Pharmaceuticals, Inc.
$12.31 from Amneal Pharmaceuticals LLC
$12.25 from Sanofi Pasteur Inc.
Payments received by Dr. Thomas Mccall, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!